𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence for using somatostatin analogues in the treatment of enterocutaneous fistula

✍ Scribed by P. Stevens; R. J. Delicata


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
88 KB
Volume
98
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of pancreatic fistula with the
✍ Dr. B. AhrΓ©n; K.-G. Tranberg; S. Bengmark πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

Somatostatin inhibits exocrine pancreatic and has been used for treatment of pancreatic f i ~t u l a ~-~. The short ti, < 3 m i n in man6, and the risk of a rebound effect when treatment is interrupted7, require the peptide to be continuously infused intravenously. This may be circumvented by using

Effects of somatostatin and a long-actin
✍ Mr J. N. Baxter; S. A. Jenkins; D. W. Day; N. B. Roberts; D. C. Cowell; C. R. Ma πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 423 KB πŸ‘ 1 views

The effects of somatostatin (SRIF) and its long-acting analogue, SMS 201-995 on the prevention and treatment of acute pancreatitis were studied in rats. Acute pancreatitis was established by ligating the bile duct at the point of entry into the duodenum, thereby allowing reflux of bile into the panc

A phase III evaluation of a somatostatin
✍ David L. Morris πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views

I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o